ArticleAlzheimer's & dementia (Amsterdam, Netherlands)
The Latin American Spanish PACC5 (LAS-PACC5): Advancing Cognitive Assessment in Latinos.
Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Latin American Spanish PACC5 (LAS-PACC5): Advancing Cognitive Assessment in Latinos.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
introductionTo address the need for validated Spanish-language cognitive assessments in Latino populations at risk for Alzheimer's disease (AD), we evaluated the psychometric performance of a Latin American Spanish adaptation of the Preclinical Alzheimer's Cognitive Composite-5 (LAS-PACC5).
methodsA total of 121 Spanish-speaking older adults from the Boston Latino Aging Study (BLAST; Mean age = 64.98 ± 6.98 years; 69% female) were included. The LAS-PACC5 replaced literacy-dependent tasks with culturally and linguistically appropriate measures. Convergent validity was examined using measures validated in diverse Spanish-speaking populations.
resultsLAS-PACC5 showed moderate associations with naming ability, episodic memory, and global cognition (all DISCUSSION: The LAS-PACC5 demonstrated convergent and discriminative validity, supporting its utility for early cognitive assessment in Spanish-speaking older adults and for improving Latino representation in AD Research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.